Validity and reproducibility of arterial pulse wave velocity measurement using new device with oscillometric technique: A pilot study by Naidu, Madireddy Umamaheshwar Rao et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
BioMedical Engineering OnLine
Open Access Research
Validity and reproducibility of arterial pulse wave velocity 
measurement using new device with oscillometric technique: A 
pilot study
Madireddy Umamaheshwar Rao Naidu*1, Budda Muralidhar Reddy1, 
Sridhar Yashmaina1, Amar Narayana Patnaik2 and Pingali Usha Rani1
Address: 1Department of Clinical Pharmacology & Therapeutics, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, 500082, India and 
2Department of Cardiology, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, 500082, India
Email: Madireddy Umamaheshwar Rao Naidu* - murnaidu@yahoo.com; Budda Muralidhar Reddy - buddamurali@yahoo.com; 
Sridhar Yashmaina - sridhar_2k8@yahoo.com; Amar Narayana Patnaik - anpatnaik@yahoo.com; Pingali Usha Rani - ushapingali@yahoo.com
* Corresponding author    
Pulse wave velocityArterial stiffness indexValidityOscillometric device
Abstract
Background: Availability of a range of techniques and devices allow measurement of many variables related to the stiffness of
large or medium sized arteries. There is good evidence that, pulse wave velocity is a relatively simple measurement and is a good
indicator of changes in arterial properties. The pulse wave velocity calculated from pulse wave recording by other methods like
doppler or tonometry is tedious, time-consuming and above all their reproducibility depends on the operator skills. It requires
intensive resource involvement. For epidemiological studies these methods are not suitable. The aim of our study was to
clinically evaluate the validity and reproducibility of a new automatic device for measurement of pulse wave velocity that can be
used in such studies.
Methods: In 44 subjects including normal healthy control and patients with coronary artery disease, heart brachial, heart ankle,
brachial ankle and carotid femoral pulse wave velocities were recorded by using a new oscillometric device. Lead I and II
electrocardiogram and pressure curves were simultaneously recorded. Two observers recorded the pulse wave velocity for
validation and one observer recorded the velocity on two occasions for reproducibility.
Results and Discussion: Pulse wave velocity and arterial stiffness index were recorded in 24 control and 20 coronary artery
disease patients. All the velocities were significantly high in coronary artery disease patients. There was highly significant
correlation between the values noted by the two observers with low standard deviation. The Pearson's correlation coefficient
for various velocities ranged from (r = 0.88–0.90) with (p < 0.0001). The reproducibility was also very good as shown by Bland-
Altman plot; most of the values were lying within 2 SD. The interperiod measurements of pulse wave velocity were also
significantly correlated (r = 0.71 – 0.98) (P < 0.0001). Carotid-femoral pulse wave velocity was found to correlate significantly
with heart brachial, heart ankle, brachial ankle pulse wave velocity and arterial stiffness index values. Reproducibility of our
method was good with very low variability in both interobserver and interperiod analysis.
Conclusion: The new device "PeriScope" based on oscillometric technique has been found to be a simple, non-invasive and
reproducible device for the assessment of pulse wave velocity and can be used to determine arterial stiffness in large population
based studies.
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Background
Interest in, and measurement of the velocity of arterial
wave propagation as an index of vascular stiffness and vas-
cular health dates back to the early part of the last century.
Many methodologies; both invasive and non-invasive
have been applied to the assessment of arterial elasticity in
vivo. The assessment of cardiovascular risk is one of the
most important tasks. The predictive value of pulse wave
velocity (PWV) is becoming increasingly recognized and it
is one of the classical indices of arterial stiffness (AS). Sev-
eral arterial assessments improve risk stratification. Three
of the most cost-effective assessment parameters are pulse
pressure, arterial stiffness and ankle brachial index. Arte-
rial stiffness can be directly measured by non-invasive
techniques like computerized oscillometry, tonometry
and ultrasonography [1].
In one study [1] of 30 patients with and without cardio-
vascular disease (CVD), the diagnostic accuracies of these
techniques were as follows: arterial stiffness 85%, pulse
pressure 71% and endothelial function 58%. Pulse pres-
sure is independently related to all cause mortality, but
only marginally related to cardiovascular mortality, indi-
cating that specific assessment of AS with PWV, may be of
greater value in the evaluation of risk [1]. PWV measure-
ments by ultrasonography are more time consuming,
requires substantial training and dedicated staff.
A recent important observation, that AS is an independent
predictor of cardiovascular mortality [2-4], has gained
greater interest. Increased stiffness may precede the onset
of clinically overt atheromatous disease [5]. Early identifi-
cation of individuals at risk, by improved detection of
changes in stiffness may help in providing beneficial
intervention at an early stage [6]. Relevance and implica-
tions of possible therapy of arterial stiffness have led to
wide spread interest in its measurement, resulting in large
number of availability of commercial devices [7]. There is
no gold standard to assess AS [8].
Recently non-invasive methods to measure AS have
become available and are relatively easy to perform [9-
12]. A simple device to measure PWV has been developed
which measures brachial ankle pulse wave velocity (ba
PWV) using an oscillometric method [13]. As it measures
peripheral artery velocity, unlike aortic PWV the clinical
significance may differ. Aortic PWV >13 m/s is a particu-
larly strong predictor of cardiovascular mortality in hyper-
tension [14]. Although ba PWV measurement is simple
and non-invasive, the sensitivity and specificity in predict-
ing coronary artery disease were only 62% and 29% [15].
A more accurate and integrated information of AS may
therefore be obtained by using a combination of tech-
niques based on different models [7]. There is a need to
quantify the extent to which measures of AS can improve
risk stratification and to determine whether its reduction
is capable of predicting clinical benefit. In the present
study, we have assessed a newly developed simple non-
invasive device, which measures both peripheral and aor-
tic PWV using an oscillometric method.
Methods
Total twenty-four male healthy subjects with mean age
24.7 ± 5.5 years, mean height 168.3 ± 5 cm and mean
weight 52.6 ± 6.4 kgs were recruited for interperiod and
interobserver reproducibility study. All the subjects gave
their consent for the study, approved by the Institutional
Ethics Committee, Nizam's Institute of Medical Sciences,
Hyderabad. Before the inclusion in the study, subjects
were thoroughly examined clinically to confirm the inclu-
sion criteria. No subject was on any medication and had
normal blood pressure, CVS, renal, hepatic functions,
blood sugar, serum cholesterol and uric acid levels.
All subjects refrained from smoking and caffeine contain-
ing beverages at least 24 hours before the measurements.
The entire test was performed in the morning, after 10
hours over night fasting condition in a quite room with
controlled temperature. In each subject two sequences of
measurements were performed, and their mean was con-
sidered for analysis. All procedures were repeated by two
observers (observer 1 and observer 2) for analysis of the
inter-observer reproducibility, between the two sequences
of measurements of PWV, the BP cuffs were rewrapped at
each measurement. For inter period reproducibility
assessment, PWV was measured twice by the same
observer with an interval of at least one day between the
two measurements.
Additionally 20 patients (9 male & 11 female) with CAD
having mean age 50 ± 13 years, mean height 157.9 ± 10
cm, mean weight 67 ± 16 kgs were also included in inter-
observer study from the OPD. History of diabetes melli-
tus, hypertension, smoking, and drug use were recorded.
All patients had coronary angiographically confirmed
CAD. Patients were allowed to take their prescribed med-
ication during the study period. All patients gave their
consent for study participation. Every time the PWV
recording was carried out at least 10 minutes after resting.
The subjects were examined in supine position. Electrodes
of electrocardiogram were placed on ventral surface of
both wrists and medial side of ankles and BP cuffs were
wrapped on both upper arm brachial artery and above tib-
ial artery of ankles. The cuffs were connected to a plethys-
mographic sensor that determines volume pulse form and
an oscillometric pressure sensor that measures blood pres-
sure volume waveforms from the brachial and tibial arter-
ies. All the pressure recordings were done for about 10
seconds and data was stored in the computer for analysis.BioMedical Engineering OnLine 2005, 4:49 http://www.biomedical-engineering-online.com/content/4/1/49
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New device (PeriScope, developed by Genesis Medical
Systems, Hyderabad, India) is an 8-channel real-time PC
based simultaneous acquisition and analysis system. The
acquisition rate is 200 samples/second, which is sufficient
because the significant frequency content of the pressure
as well as ECG waveform is not more than 40 Hz. Accord-
ing to Nyquist's criteria the minimum sampling rate
should be 80 samples/second. Hence a sampling rate of
200 Hz per second is optimum. It supports a sophisticated
digital signal-processing algorithm to calculate all the
results. System has dedicated hardware module connected
to 4 ECG electrodes and 4 Blood pressure measuring cuffs.
It is very user friendly and fully automatic. Once started,
the test recording completes itself by displaying results
directly. The report contains 8-second traces of Lead I and
II ECG, all Pressure Pulse Waveforms and all calculated
results. Device has a built-in database that can be used to
store patient folders for further referrals at any point of
time. PeriScope is a PC based low cost instrument. When
used with a laptop, it can be carried to remote locations.
It uses of ECG as marker. It does not use phonocardio-
gram. PeriScope thus facilitates use in epidemiological
studies.
Calculation of pulse wave velocity by oscillometric method
This method measures the blood pressure by detecting the
pulsation of the artery, which is caused by the heart, as the
pressure oscillation in the cuff. When the cuff around< the
upper arm is fully inflated, blood flow stops but pulsation
of the artery continues and causes oscillation of the pres-
sure in the cuff. As the pressure in the cuff is decreased
slowly, the amplitude of the pressure oscillation in the
cuff gradually increases and eventually reaches to a peak.
Further decrease of the cuff pressure causes the oscillation
amplitude to decrease. Cuff pressure when the oscillation
reaches a peak, is taken as the mean arterial pressure
(MAP).
Figure 1 shows the oscillometric pressure pattern. As this
maximum amplitude oscillation in each limb is detected,
the pulse waveform along with ECG Lead I and II are
stored simultaneously in the PC memory. These wave-
forms are used to detect various pulse wave velocities as
described below.
Pulse wave velocity is the speed at which the blood pres-
sure pulse travels from the heart to the peripheral artery
after blood rushes out during contraction. It is mainly
used to evaluate stiffness of the artery wall. Pulse wave
velocity increases with stiffness of the arteries.
With new device, the PTT (Pulse Transit Time) of each seg-
ment is calculated from the waveform taken from each
sensor.
It calculates heart-brachial PWV of both upper limbs,
heart-ankle PWV of both lower limbs, brachial-ankle PWV
of both right and left limb pairs and effective estimated
carotid-femoral PWV is calculated.
Where Lha = Distance between heart and respective ankle.
Lhb = Distance between heart and respective brachium.
Lba = Distance between respective brachium and ankle.
Distances were measured by direct superficial measure-
ment with a measuring tape of 1 mm resolution as
follows:
Heart to brachial distance = Heart to shoulder + shoulder
to midpoint of brachial cuff.
Heart to ankle distance = Heart to midpoint of ankle cuff.
Brachial ankle distance = Heart to brachial distance +
Heart to ankle distance
Pulse Transit Time (PTT) between heart and extremity (i.e.
PTT hb and PTT ha) is calculated using R wave as pulse
start maker and maximum pressure gradient as pressure
wave arrival marker. This is due to the fact that the QRS
complex designates highest-pressure deviation in the left
ventricle where as maximum pressure gradient marks the
highest-pressure deviation in the artery of the extremity
(Fig. 2). A proprietary software algorithm is used to ana-
lyze the ECG and pressure waveforms. From this analysis
the pre-ejection period is calculated and deducted from
each "R-wave to max. pressure gradient" time. This gives
the actual pulse transit time.
Pulse Transit Time (PTT) between brachium and respec-
tive ankle is calculated as the time difference between the
feet of respective pulse wave originated by the same QRS
complex. The carotid femoral PWV (C-F PWV) is esti-
mated from the composite brachial ankle pulse wave
velocity (ba PWV) found out by averaging left and right ba
PWV
L distance
PTT  Pulse Transit Time
=
()
()
ha PWV  heart-ankle PWV
Lha
PTTha
() =
hb PWV  heart-brachial PWV
Lhb
PTThb
() =
ba PWV  brachial-ankle PWV
Lba
PTTba
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PWV. The regression analysis between ba PWV and C-F
PWV yields the following equation:
Estimated carotid femoral PWV = 0.8333 * (Avg. ba PWV)
- 233.33.
This equation is arrived at by internal data collection and
confirmed by studies conducted elsewhere [13].
Derivation of oscillometric envelopes
Oscillometric envelope is a graphical depiction of com-
pressibility of the artery. It is derived from the oscillations
in the artery when the BP cuffs are deflating while taking
the BP reading. It is the graph of amplitude of oscillations
verses the instantaneous pressure in the blood pressure
cuff. In a normal arterial condition, the shape of the oscil-
lometric envelope is like a bell, when arteries are stiffened
or atherosclerosed the oscillometric envelope flattens out.
Calculation of arterial stiffness index
Arterial stiffness index is another measure of arterial stiff-
ness. It quantifies the shape of the oscillometric envelope.
As the arterial stiffness increases, it becomes harder to col-
lapse the arteries by applying external pressure; hence the
oscillometric envelope becomes flatter as the stiffness
increases. The ASI value gives a clear indication of this flat-
tening process (Fig. 3). The higher the stiffness, the higher
the ASI values. It is calculated as:
ASI = (Systolic side Value of cuff pressure at 80% of max-
imal oscillation amplitude of cuff) - (Diastolic side Value
of cuff pressure at 80% of maximal oscillation amplitude
of cuff).
The device acquires and computes the following parame-
ters simultaneously: 2 channels of ECG, brachial BP of
both limbs, ankle BP of both limbs, 4 channels of pulse
Computerized oscillomertry Figure 1
Computerized oscillomertry. Atypical computerized Oscillometric pattern of pressure.BioMedical Engineering OnLine 2005, 4:49 http://www.biomedical-engineering-online.com/content/4/1/49
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pressure waveforms, mean arterial pressure (MAP), %
MAP, ABI, pulse wave velocities, UT (Upstroke Time),
arterial stiffness index.
Statistics
Data are expressed as mean ± SD. Pearson's correlation
analysis, determination of coefficient of variation and
Bland-Altman plotting were performed for the assessment
of validity and reproducibility [21]. When two series of
paired measurements were compared, the results were
analyzed in two steps according to the recommendations
of Bland and Altman. First, the correlation between meas-
urement values (equation of the linear relationship, corre-
lation coefficient r, and P value) was investigated. The first
step was used to gauge the degree of agreement between
two series of measurements. Second, the relative (positive
or negative) differences between each pair of measures
were plotted against the mean of the pair to make sure
that no obvious relation appeared between the estimated
value mean and difference. The mean difference and the
SD of the differences estimated the lack of agreement
between the two measurements. Unpaired student 't' test
was used for comparisons among the two groups. Values
of p < 0.05 was considered to indicate statistical signifi-
cance. All the statistical analysis was performed using the
Graph pad PRISM software version 4 (Graph pad software
Inc. San Diego, California, USA).
Results
Total 44 subjects (24) healthy controls and (20) CAD
patients participated in the present study. The demo-
graphic characteristic of all subjects is shown in the table-
1. As our aim was to study the reproducibility and validity
of a new method, we have selected both healthy controls
Pulse Wave Velocity calculations Figure 2
Pulse Wave Velocity calculations. Reference points of ECG and four pressure waveforms consider for calculation of pulse 
transit time and PWV.
Heart to Right Brachial Cuff Distance
Right hb PWV = -----------------------------------------------------------
∆ T1
Heart to Left Brachial Cuff Distance
Left hb PWV = -----------------------------------------------------------
∆ T2
Heart to Right Ankle Cuff Distance
Right ha PWV = --------------------------------------------------------
∆ T3
Heart to Left Ankle Cuff Distance
Left ha PWV = -------------------------------------------------
∆ T4
Right Ankle to Right Brachial Cuff Distance
Right ba PWV = --------------------------------------------------------------
∆ T5
Left Ankle to Left Brachial Cuff Distance
Left ba PWV = -------------------------------------------------------------
∆ T6BioMedical Engineering OnLine 2005, 4:49 http://www.biomedical-engineering-online.com/content/4/1/49
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Oscillometric Envelopes Figure 3
Oscillometric Envelopes.
Table 1: Demographic characteristics of healthy subjects and patients with coronary artery disease (CAD) studied.
All Subjects Healthy subjects CAD patients
Number 44 24 20
Sex (male/female) 33/11 24/0 9/11
Age (yrs) 37.09 ± 16.69 24.67 ± 4.65 52.00 ± 13.22***
Weight (Kgs) 59.18 ± 13.73 52.67 ± 6.46 67.00 ± 16.04##
Height (cms) 163.5 ± 9.342 168.3 ± 5.18 157.9 ± 10.14***
BMI (Kg/m2) 22.26 ± 5.331 18.65 ± 2.46 26.59 ± 4.54***
Heart Rate (bpm) 71.13 ± 15.69 62.33 ± 7.56 81.80 ± 16.47***
Systolic BP (mmHg) 106.4 ± 13.46 110.3 ± 8.8 131.9 ± 21.95*
Diastolic BP (mmHg) 58.85 ± 12.99 63.08 ± 6.6 79.15 ± 11.38**
MAP (mmHg) 82.78 ± 9.68 85.1 ± 6.64 100.9 ± 15.8#
Pulse Pressure 46.64 ± 11.77 47.17 ± 5.59 52.7 ± 16.08***
Values are expressed as Mean ± SD.
*** p < 0.0001, ** p < 0.0003, * p < 0.01, # #p < 0.0002 and # p < 0.02 Vs Healthy subjects.BioMedical Engineering OnLine 2005, 4:49 http://www.biomedical-engineering-online.com/content/4/1/49
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and CAD patients. The control group had lower mean age
than the CAD group; similarly the BMI was also high in
CAD group. As compared to control group, all haemody-
namic parameters HR, SBP, DBP, PP and MAP were also
significantly higher in CAD group.
The mean PWV obtained in two groups is shown in table
2. In CAD group hb PWV, ha PWV, ba PWV and C-F PWV
were found to be significantly higher than control. The
mean ankle ASI was 60.6 ± 16.7 in CAD group and 48.2 ±
7.6 in control. This difference in ankle ASI was significant
(p < 0.001).
The mean velocities obtained by the two separate observ-
ers in control and CAD group are shown in tables 3, 4 and
5. Values of all parameters obtained by two observers were
found to be highly correlated with significant Pearson's
correlation coefficients.
Table 2: Pulse Wave Velocity and Arterial Stiffness Index.
Pulse Wave Velocity All Subjects Healthy subjects CAD patients
Number of observations 88 48 40
Heart Brachial PWV
Mean 279.0 262.4 298.9***
SD 45.10 17.03 58.67
SE 4.808 2.459 9.276
Heart Ankle PWV
Mean 482.8 425.1 551.9***
SD 85.97 17.28 84.50
SE 9.165 2.494 13.36
Brachial Ankle PWV
Mean 1392 1115 1725***
SD 397.3 103.8 362.1
SE 42.36 14.99 57.25
Carotid Femoral PWV
Mean 930.7 702.7 1204***
SD 329.2 90.54 301.8
SE 35.09 13.07 47.72
Brachial ASI
Mean 38.08 37.41 38.89
SD 10.23 4.373 14.46
SE 1.090 0.6312 2.287
Ankle ASI
Mean 53.84 48.22 60.59***
SD 13.97 7.601 16.73
SE 1.489 1.097 2.646
*** p < 0.0001 Vs Healthy subjects
Table 3: Means and correlational analysis (Pearson r value) of arterial stiffness among healthy subjects (n = 24)
Pulse Wave 
Velocity
Observer I Observer II Pearson (r) 95% CI P value
Heart Brachial PWV 262.4 ± 16.09 262.4 ± 18.28 0.88 0.75 to 0.95 p < 0.0001
Heart Ankle PWV 425.4 ± 17.96 424.9 ± 16.96 0.91 0.80 to 0.96 p < 0.0001
Brachial Ankle PWV 1124 ± 104 1106 ± 105.2 0.89 0.76 to 0.95 p < 0.0001
Carotid Femoral PWV 706.2 ± 90.36 699.2 ± 92.53 0.90 0.79 to 0.96 p < 0.0001
Brachial ASI 37.80 ± 3.93 37.01 ± 4.83 0.62 0.28 to 0.82 p < 0.001
Ankle ASI 48.39 ± 8.54 48.06 ± 6.71 0.85 0.69 to 0.94 p < 0.0001
Values are expressed as Mean ± SDBioMedical Engineering OnLine 2005, 4:49 http://www.biomedical-engineering-online.com/content/4/1/49
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In the control group, the Pearson's correlation coefficient
was 0.88, 0.91, 0.89 and 0.90 (p < 0.0001) for hb, ha, ba
and C-F PWV respectively. The coefficient was 0.85 for
ankle ASI with p < 0.0001. Similarly in CAD group, and in
data from all subjects combined also the correlation was
highly significant, suggesting high reproducibility of our
method for PWV determination.
The relationship and Bland-Altman plot for hb, ha, ba and
C-F PWV obtained by two observers is shown in figures 4,
5, 6 and 7 respectively. A very good correlation was
observed between the two measurements (r = 0.98 – 0.99)
in all these above parameters. There was no trend for the
reproducibility of measurements to vary with the underly-
ing mean values in any of the parameters analyzed. In the
Bland-Altman Plots of interobserver measurements of
PWV, there was no significant difference in the values for
reproducibility reported between observers and most of
the values ranged within a mean ± 2 SD.
The mean of hb, ha, ba, C-F PWV and ASI recorded during
two-separate occasions in same subject was shown in the
table 6. The relationship and Bland-Altman plot of two
period measurements are shown in figure 8, 9, 10 and 11.
The measurements of PWV had significant correlation
with (r = 0.71 – 0.98). There was significantly less varia-
tion in reproducibility as clearly shown in Bland-Altman
plot. Most of the values of PWV are lying within the mean
± 2 SD. The present study demonstrated, considerably
high Pearson's correlation coefficients for both interob-
server and interperiod reproducibility in PWV measure-
ments with new device. Correlation analysis of carotid
femoral PWV with other PWV parameters obtained is
shown in table 7. Both brachial and ankle ASI, hb, ha, and
ba PWV correlated significantly with C-F PWV. The Pear-
son's correlation coefficient was 0.99 for brachial ankle
PWV and was 0.30 for brachial ASI.
Our present study was not aimed to detect differences in
the measured parameters between control group and CAD
group; therefore no sub group analysis was performed.
The CAD group was included to provide a wide range of
PWV values, thus strengthening the reproducibility of
method.
Discussion
In recent years with the development of readily available
noninvasive assessment techniques investigation of arte-
rial stiffness, especially of the large arteries has gathered
pace. These include the measurement of PWV, the use of
ultrasound to relate the change in diameter or area of an
artery to distending pressure and analysis of arterial wave
forms obtained by applanation tonometry. For the meas-
urement of AS, several new techniques have been
developed, but their association with aortic PWV, an
established measure of central arterial stiffness has not
Table 4: Means and correlational analysis (Pearson r value) of arterial stiffness among CAD Patients (n = 20)
Pulse Wave 
Velocity
Observer I Observer II Pearson (r) 95% CI P value
Heart Brachial PWV 298.9 ± 59.26 298.9 ± 59.61 0.99 0.97 to 0.99 p < 0.0001
Heart Ankle PWV 550.3 ± 83.60 553.5 ± 87.53 0.98 0.96 to 0.99 p < 0.0001
Brachial Ankle PWV 1719 ± 368.8 1731 ± 364.8 0.99 0.98 to 0.99 p < 0.0001
Carotid Femoral PWV 1199 ± 307.4 1210 ± 304 0.98 0.97 to 0.99 p < 0.0001
Brachial ASI 39.15 ± 14.21 38.63 ± 15.07 0.93 0.85 to 0.97 p < 0.0001
Ankle ASI 60.48 ± 17.77 60.70 ± 16.09 0.95 0.88 to 0.98 p < 0.0001
Values are expressed as Mean ± SD
Table 5: Means and correlational analysis (Pearson r value) of arterial stiffness among all subjects (Healthy + CAD) (n = 44)
Pulse Wave 
Velocity
Observer I Observer II Pearson (r) 95% CI P value
Heart Brachial PWV 279.0 ± 45.05 279.0 ± 45.67 0.98 0.96 to 0.99 p < 0.0001
Heart Ankle PWV 482.2 ± 84.97 483.3 ± 87.94 0.99 0.98 to 0.99 p < 0.0001
Brachial Ankle PWV 1394 ± 394.7 1390 ± 404.5 0.99 0.98 to 0.99 p < 0.0001
Carotid Femoral PWV 940.7 ± 331.7 941 ± 338.3 0.99 0.98 to 0.99 p < 0.0001
Brachial ASI 38.41 ± 9.8 37.74 ± 10.65 0.91 0.85 to 0.95 p < 0.0001
Ankle ASI 53.88 ± 14.69 53.81 ± 13.38 0.94 0.90 to 0.96 p < 0.0001
Values are expressed as Mean ± SDBioMedical Engineering OnLine 2005, 4:49 http://www.biomedical-engineering-online.com/content/4/1/49
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been validated. Because of its size and elasticity, the aorta
is the main determinant of systemic arterial compliance
[16] and thus AS models incorporating wave reflection are
influenced by both central and peripheral AS. Central
stiffness is most commonly assessed using aortic PWV,
which is a robust measurement and predictive of cardio-
vascular morbidity in hypertensive [17] and non-hyper-
tensive subjects [18,19]. Aortic PWV can also be measured
non-invasively by using MRI [20]. It has potential advan-
tage of accurate determination of path length, however its
use is very much limited due to prolonged time required
to make recording, lack of availability in the clinical set-
tings, high cost for measurement and difficulty in per-
forming within a strong magnetic field.
Perhaps the best and most widely used technique to esti-
mate the distensibility and stiffness of the aorta and prox-
imal vessels is PWV. Although the properties of large
arteries have been studied for several decades, the field of
clinical arterial biomechanics remains in its infancy. The
clinical value of any of the available techniques is yet to be
proved convincingly and no single parameter of compli-
ance or stiffness can ever be expected to describe all clini-
cally relevant arterial wall properties. Measurement error
can be substantial, including problems related to the
measurement of both transit time and distance traveled by
the pulse wave. There is a need for a simple, reliable, non-
invasive method of detecting early disturbances at the
time when therapeutic intervention can be most benefi-
cial. Currently, none of the methodologies available are
Interobserver Heart Brachial PWV Figure 4
Interobserver Heart Brachial PWV. Relationship 
between two independent measurements of hb PWV by two 
observers (Upper panel). Reproducibility of hb PWV. Bland-
Altman plot showing observer difference in measurements. 
(Lower panel).
150 200 250 300 350 400 450 500
150
200
250
300
350
400
450
500
(cm/sec)
(cm/sec)
(r: 0.98) (P<0.0001)
(n=44)
Observer 1
O
b
s
e
r
v
e
r
2
100 200 300 400 500
-50
-40
-30
-20
-10
0
10
20
30
40
50
(cm/sec)
(cm/sec)
Mean + 2SD
Mean - 2SD
Bland Altman Plot
D
i
f
f
e
r
e
n
c
e
b
e
t
w
e
e
n
t
w
o
m
e
a
s
u
r
e
m
e
n
t
s
Interobserver Heart Ankle PWV Figure 5
Interobserver Heart Ankle PWV. Relationship between 
two independent measurements of ha PWV by two observ-
ers (Upper panel). Reproducibility of ha PWV. Bland-Altman 
plot showing observer difference in measurements. (Lower 
panel).
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Interobserver Brachial Ankle PWV Figure 6
Interobserver Brachial Ankle PWV. Relationship 
between two independent measurements of ba PWV by two 
observers (Upper panel). Reproducibility of ba PWV. Bland-
Altman plot showing observer difference in measurements. 
(Lower panel).
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Interobserver Carotid Femoral PWV Figure 7
Interobserver Carotid Femoral PWV. Relationship 
between two independent measurements of C-F PWV by 
two observers (Upper panel). Reproducibility of C-F PWV. 
Bland-Altman plot showing observer difference in measure-
ments. (Lower panel).
500 1000 1500 2000 2500
-200
-150
-100
-50
0
50
100
150
200
(cm/sec)
(cm/sec)
Mean + 2SD
Mean - 2SD
Bland - Altman Plot
D
i
f
f
e
r
e
n
c
e
b
e
t
w
e
e
n
t
w
o
m
e
a
s
u
r
e
m
e
n
t
s
400 800 1200 1600 2000 2400
400
800
1200
1600
2000
2400
(cm/sec)
(cm/sec)
(r: 0.99) (P<0.0001)
(n=44)
Observer1
O
b
s
e
r
v
e
r
2
Table 6: Means and correlational analysis (Pearson r value) of arterial stiffness among all subjects (Healthy + CAD) (n = 24)
Pulse Wave 
Velocity
Period I Period II Pearson (r) 95% CI P value
Heart Brachial PWV 263.6 ± 15.38 263.6 ± 17.59 0.71 0.43 to 0.86 p < 0.0001
Heart Ankle PWV 424.4 ± 19.73 425.5 ± 15.74 0.86 0.70 to 0.93 p < 0.0001
Brachial Ankle PWV 1111 ± 105.7 1119 ± 104.1 0.98 0.96 to 0.99 p < 0.0001
Carotid Femoral PWV 698.6 ± 91.28 706.8 ± 91.58 0.94 0.96 to 0.97 p < 0.0001
Brachial ASI 37.08 ± 4.72 37.27 ± 3.95 0.84 0.67 to 0.93 p < 0.0001
Ankle ASI 48.88 ± 7.10 46.99 ± 7.85 0.81 0.65 to 0.91 p < 0.0001
Values are expressed as Mean ± SDBioMedical Engineering OnLine 2005, 4:49 http://www.biomedical-engineering-online.com/content/4/1/49
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the differences between the paired measurements. This
method was used rather than only reporting coefficient of
variance, as the latter is a less satisfactory method of
assessing reproducibility and can some time misleading
[21].
Arterial stiffness index (ASI) also well correlated with C-F
PWV (r = 0.67, p < 0.0001). Similar correlation between
ASI and C-F PWV has been documented earlier in elderly
hypertensive patients [22]. Our results indicate that, non-
invasive PWV measurements with new device were repro-
ducible. Both within observer and between the observers,
reproducibility was high with low SD for measurement
differences. The lower value for between observer differ-
ences reflects the fact that, the means of two readings
made by each observer are comparable, thus reducing var-
iability. The method we used to measure PWV does not
require any specialized technique and the examiner only
has to wrap cuffs on all the limbs and place electrodes for
recording lead II ECG. Our study demonstrated high Pear-
son's correlation coefficient for interobserver and interpe-
riod reproducibility. In the Bland-Altman plot the
deviation was greater at high PWV values. A similar
deviation has also been reported in the measurements of
C-F PWV [23]. It is known that, the variability in measure-
ment of PWV increases when PWV are high due to
confounding factors like high blood pressure, blood flow
[24], and high sympathetic tone [25]. In our study though
we have included CAD patients, the deviation in measure-
ments ranged within a mean ± 2SD even with high PWV.
Interperiod Heart Brachial PWV Figure 8
Interperiod Heart Brachial PWV. Relationship between 
measurements of hb PWV between two different periods 
(Upper panel). Reproducibility of hb PWV. Bland-Altman plot 
showing difference in measurement between two periods. 
(Lower panel).
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Interperiod Heart Ankle PWV Figure 9
Interperiod Heart Ankle PWV. Relationship between 
measurements of ha PWV between two different periods 
(Upper panel). Reproducibility of ha PWV. Bland-Altman plot 
showing difference in measurement between two periods. 
(Lower panel).
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Furthermore both interobserver and interperiod coeffi-
cient variations were less than 20 %. We made compari-
son of interobserver and interperiod measurements with
both Bland-Altman and correlation analysis. Unlike corre-
lation analysis, Bland-Altman Plots do not assume zero
error for either of the two measurements under compari-
son and therefore is a better indicator of the true agree-
ment between the measurements [26]. We noted
significant association of correlations analysis between C-
F PWV and other PWV and ASI, with low variability in
Bland-Altman analysis.
There are a number of different ways to measure PWV,
and these are generally simple to perform.
Interperiod Brachial Ankle PWV Figure 10
Interperiod Brachial Ankle PWV. Relationship between 
measurements of ba PWV between two different periods 
(Upper panel). Reproducibility of ba PWV. Bland-Altman plot 
showing difference in measurement between two periods. 
(Lower panel).
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Interperiod Carotid Femoral PWV Figure 11
Interperiod Carotid Femoral PWV. Relationship 
between measurements of C-F PWV between two different 
periods (Upper panel). Reproducibility of C-F PWV. Bland-
Altman plot showing difference in measurement between 
two periods. (Lower panel).
Table 7: The correlation between carotid-femoral PWV and 
other variables evaluated in all subjects (Healthy + CAD) (n = 
88)
P-Value Pearson (r)
Brachial ASI <0.005 0.30
Ankle ASI <0.0001 0.67
Heart Brachial PWV <0.0004 0.37
Heart Ankle PWV <0.0001 0.83
Brachial Ankle PWV <0.0001 0.99
ASI, arterial stiffness index; PWV, pulse wave velocity
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Conclusion
The results of this study indicate that, the measurement of
arterial PWV by oscillometric technique using PeriScope is
reproducible and simple. The validity and reproducibility
of the measurement of PWV in interobserver and interpe-
riod evaluation was high with a low SD for measurement
difference. Derived carotid femoral velocity correlated
well with hb, ha and ba PWV and arterial stiffness index.
Simultaneous measurement of all velocities and stiffness
index provide better over all assessment of arterial
functions. New device may be useful in studying arterial
stiffness in large population.
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C-F – Carotid Femoral
CV – Coefficient of variation
CVD – Cardiovascular Disease
DBP – Diastolic blood pressure
DSP – Digital signal processing
ECG – Electrocardiogram
ha – Heart ankle
hb – Heart brachial
HR – Heart rate
MAP – Mean Arterial Pressure
OPD – Out Patient Department
PP – Pulse pressure
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